Education
About Us
Working with TipRanks
Follow Us
Ekso Bionics Holding (EKSO)
:EKSO
EKSO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.37 - $1.64
Previous CloseN/A
Volume1.71M
Average Volume (3M)323.63K
Market Cap
$11.82M
Enterprise Value$21.61M
Total Cash (Recent Filing)$8.80M
Total Debt (Recent Filing)$6.84M
Price to Earnings (P/E)―
Beta1.43
Next Earnings
Apr 24, 2025EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding24,824,762
10 Day Avg. Volume179,462
30 Day Avg. Volume323,634
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.60
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market Cap1.83
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.27
Enterprise Value/Ebitda-2.41
Forecast
1Y Price Target
$6.33Price Target Upside1218.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
EKSO BIONICS News
PremiumCompany Announcements
Ekso Bionics’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Ekso Bionics Reports Record Q4 Revenue and Strategic Partnership
---
Bulls Say, Bears Say
Bulls Say
Revenue Growth OutlookRevenue growth is expected in both the legacy enterprise business and Indego Personal, indicating a positive outlook for 2025.
Strategic PartnershipsStrategic partnerships have been formed to broaden access to Ekso Indego Personal and navigate the reimbursement process, potentially expanding the market and driving long-term value for Ekso.
Bears Say
Medicare Reimbursement ChallengesThe entire process of Medicare Part B reimbursement for Indego Personal devices is moving more slowly than anticipated, leading to investor disappointment.
---
Ownership Overview
6.31% Insiders
3.37% Mutual Funds
12.55% Other Institutional Investors
75.13% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
EKSO FAQ
What was Ekso Bionics Holding’s price range in the past 12 months?
Ekso Bionics Holding lowest stock price was $0.37 and its highest was $1.64 in the past 12 months.
What is Ekso Bionics Holding’s market cap?
Ekso Bionics Holding’s market cap is $11.82M.
When is Ekso Bionics Holding’s upcoming earnings report date?
Ekso Bionics Holding’s upcoming earnings report date is Apr 24, 2025 which is in 50 days.
How were Ekso Bionics Holding’s earnings last quarter?
Ekso Bionics Holding released its earnings results on Mar 03, 2025. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.08 by -$0.06.
Is Ekso Bionics Holding overvalued?
According to Wall Street analysts Ekso Bionics Holding’s price is currently Undervalued.
Does Ekso Bionics Holding pay dividends?
Ekso Bionics Holding does not currently pay dividends.
What is Ekso Bionics Holding’s EPS estimate?
Ekso Bionics Holding’s EPS estimate is -0.11.
How many shares outstanding does Ekso Bionics Holding have?
Ekso Bionics Holding has 24,824,762 shares outstanding.
What happened to Ekso Bionics Holding’s price movement after its last earnings report?
Ekso Bionics Holding reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.08. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ekso Bionics Holding?
Currently, no hedge funds are holding shares in EKSO
---
Company Description
Ekso Bionics Holding
Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in Richmond, CA.
---
EKSO Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative trends. While there were record-breaking quarterly revenues, improved margins, and strategic partnerships, there were also challenges such as a decline in full-year revenue and increased net loss for the quarter. The company's strategic efforts to enhance market access and reimbursement processes indicate optimism for future growth.Read More>---
EKSO Stock 12 Month Forecast
Average Price Target
$6.33
▲(1218.75% Upside)
Technical Analysis
Best Analysts Covering EKSO
1 Year
1 Year Success Rate
1/10 ratings generated profit
1 Year Average Return
-38.85%
reiterated a buy rating 2 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 10.00% of your transactions generating a profit, with an average return of -38.85% per trade.
---